7497-87-2

Basic information

• Product Name: 1-(3-BROMOPROPOXY)-4-BROMOBENZENE
• Synonyms: 1-(3-Bromopropoxy)-4-bromobenzene;NSC406842;1-bromo-4-(3-bromopropoxy)benzene;4-Bromophenyl3-bromopropylether
• CAS NO: 7497-87-2
• Molecular Formula: C₉H₁₀Br₂O
• Molecular Weight: 293.9831
• Mol File: 7497-87-2.mol
• Article Data: 22

Chemical Properties

• Boiling Point: 324.1 °C at 760 mmHg
• Flash Point: 131.2 °C
• Appearance: /
• Density: 1.672 g/cm³
• Vapor Pressure: 0.000474mmHg at 25°C
• Refractive Index: 1.569
• CAS DataBase Reference: 1-(3-BROMOPROPOXY)-4-BROMOBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-BROMOPROPOXY)-4-BROMOBENZENE(7497-87-2)
• EPA Substance Registry System: 1-(3-BROMOPROPOXY)-4-BROMOBENZENE(7497-87-2)

Safety Data

• Hazardous Substances Data: 7497-87-2(Hazardous Substances Data)

Usage

General Description

1-(3-Bromopropoxy)-4-bromobenzene is a chemical compound with the molecular formula C9H9Br2O. It is a derivative of benzene, containing two bromine atoms and a propoxy group attached to the benzene ring. 1-(3-BROMOPROPOXY)-4-BROMOBENZENE is used in organic synthesis and as an intermediate in the production of various pharmaceuticals and agrochemicals. It is also a useful building block for creating other organic compounds with specific properties and functions. Due to its bromine atoms, it is considered hazardous and should be handled and used with appropriate safety measures.

InChI:InChI=1/C9H10Br2O/c10-6-1-7-12-9-4-2-8(11)3-5-9/h2-5H,1,6-7H2

Upstream product

• 106-41-2 4-bromo-phenol 
• 109-64-8 1,3-dibromo-propane 
• 627-18-9 1-bromo-3-propanol 
• 67900-64-5 3-(4-Bromophenoxy)-1-propanol 
• 124-63-0 methanesulfonyl chloride 
• 121-44-8 triethylamine 
• 55580-07-9 4-(4-bromophenoxy)butanoic acid 
• 157245-87-9 4-(4-bromophenoxy)butyric acid ethyl ester 
• 25244-30-8 4-(allyloxy)bromobenzene 

Downstream Products

• 7494-06-6 3-(4-bromo-phenoxy)-propylsulfanyl cyanate 
• 588-63-6 3-phenoxypropyl bromide 
• 108-95-2 phenol 
• 76579-64-1 3-(4-bromophenoxy)-N,N-dimethyl-propan-1-amine 
• 1026543-63-4 N-[3-(4-bromo-phenoxy)-propoxy]-acetamide 
• 93699-37-7 1-bromo-4-[3-(4-methylpiperazin-1-yl)propoxy]benzene 
• 238093-19-1 dimethyl-[3-(4-trimethylsilanyl-phenoxy)-propyl]-amine 
• 1235866-08-6 9-O-[3-(4-bromo-phenoxy)propyl]berberine bromide 
• 1312478-67-3 1-[3-(4-bromophenoxy)propyl]-4,4-difluoropiperidine 
• 1354972-11-4 methyl 2-((3-(4-bromophenoxy)propyl)(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)amino)acetate 
• 1354972-13-6 ethyl 2-((3-(4-bromophenoxy)propyl)(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)amino)acetate 
• 1354972-15-8 tert-butyl-2-((3-(4-bromophenoxy)propyl)(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)amino)acetate 
• 1354972-01-2 1-(allyl(3-(4-bromophenoxy)propyl)amino)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol 

Relevant articles and documents

Preparation method 3 - phenoxybromopropane or analogue thereof

The invention discloses a preparation method of 3 -phenoxybromopropane or an analogue thereof, wherein 3 - phenoxybromopropane and an allyl compound thereof are obtained through substitution reaction and addition reaction so as to avoid the inconvenience of using gaseous hydrogen bromide, 2nd-step addition reaction is realized by using the brominated salt and the acid in situ, and the process is simple in operation. The condition is easy to control, the atom economy is good, the aspect of environmental impact is low pollution, zero emission accords with the current green chemical synthesis direction, and the cost is economic.

POLYCYCLIC COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES

The present disclosure relates to bifunctional compounds, ULM— L—PTM, which find utility as modulators of Rapidly Accelerated Fibrosarcoma (RAF, such as c-RAF, A- RAF and/or B-RAF; the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein RAF, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein, or the constitutive activation of the target protein, are treated or prevented with compounds and compositions of the present disclosure.

Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis

Clinical treatment of cryptococcal meningitis (CM) remains a significant challenge because of the lack of effective and safe drug therapies. Developing novel CM therapeutic agents with novel chemical scaffolds and new modes of action is of great importanc